About Geno Pharmaceuticals
Geno Pharmaceuticals is a Healthcare company based in Mapusa (India) founded in 1975. Pharmaceutical manufacturing, healthcare solutions, and veterinary services in India. The company has 1,181 employees. Its Indian entity Geno Pharmaceuticals Private Limited reported revenue of ₹349 Cr. Geno Pharmaceuticals offers products and services including Geno Shakti and Geno Shaurya. Its focus areas include Animal Health, Veterinary Services, Animal Care Products and Pharmaceuticals.
Company details
Geno Pharmaceuticals Pvt. Ltd. is established as a key player in the pharmaceutical industry, with operations grounded in divisions like Geno Shakti, Geno Shaurya, and Clean Care that focus on healthcare and dermatological solutions. A network of 24 depots and over 1298 distributors is maintained across major Indian cities, supported by a field sales force of 680. Founded in 1975, the company is guided by experienced directors and has demonstrated commitments through CSR initiatives, such as donations during the COVID-19 pandemic, to enhance community health and animal well-being.
- Headquarters Mapusa, India
- Employees 1,181
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genopharma.com
- Legal Name Geno Pharmaceuticals Pvt. Ltd
- Date of Incorporation 04 Dec, 1975
- Jurisdiction Goa, India
- Annual Revenue₹349 Cr
FY 2025 · +14% YoY
- Net Profit₹36.05 Cr
FY 2025 · 10% margin
- EBITDA₹56.27 Cr
FY 2025 · 16% margin
- Employee Count1,181
Associated legal entities of Geno Pharmaceuticals
Geno Pharmaceuticals operates through Geno Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Geno Pharmaceuticals Private Limited CIN U24239GA1975PTC000250 | Active | 04 Dec 1975 | ₹349 Cr | 1,042 | 7 | View details |
Products & Services of Geno Pharmaceuticals
Geno Pharmaceuticals offers a comprehensive portfolio of products and services, including Geno Shakti and Geno Shaurya.
Healthcare solutions are provided by Geno Shakti as a flagship division focused on becoming a strong provider in the sector
High-quality medications are distributed by Geno Shaurya, which are designed to be affordable and effective for various needs
Board of directors of Geno Pharmaceuticals Private Limited (Geno Pharmaceuticals)
Geno Pharmaceuticals Private Limited is the primary company behind Geno Pharmaceuticals. The board of Geno Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Dilip Salgaocar Ramacrisna, appointed in 1980. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilip Salgaocar Ramacrisna DIN 00044240 | Director | 01 Jan 1980 | 46 yrs 10 mo | Geno Pharmaceuticals Private Limited |
| Pallavi Sagar Salgaocar DIN 00044805 | Whole-time director | 30 Sep 2004 | 22 yrs 1 mo | Geno Pharmaceuticals Private Limited |
| Pramod Dilip Salgaocar DIN 00044595 | Whole-time director | 30 Sep 2006 | 20 yrs 1 mo | Geno Pharmaceuticals Private Limited |
| Sagar Dilip Salgaocar DIN 00044689 | Managing Director | 01 Oct 2010 | 16 yrs 1 mo | Geno Pharmaceuticals Private Limited |
| Suriakiran Umacanta Sinaikunde DIN 06960059 | Director | 25 Oct 2014 | 12 yrs | Geno Pharmaceuticals Private Limited |
| Shivam Sagar Salgaocar DIN 10365889 | Director | 23 Oct 2023 | 3 yrs | Geno Pharmaceuticals Private Limited |
Financials of Geno Pharmaceuticals
Figures of Geno Pharmaceuticals Private Limited, the primary company behind Geno Pharmaceuticals, for FY 2025. Revenue was ₹349 Cr (+14% year on year). Net profit was ₹36.05 Cr (10% margin). EBITDA was ₹56.27 Cr (16% margin). Revenue has grown at a compounded annual rate of +10% over three years and +12% over five years.
- ₹349 CrRevenue · FY 2025 · +14% YoY
- ₹36.05 CrNet profit · 10% margin
- ₹56.27 CrEBITDA · 16% margin
- ₹3.00 CrPaid-up capital
- 1,042Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Geno Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Geno Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Geno Pharmaceuticals
The website of Geno Pharmaceuticals (genopharma.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 12.4% vs previous month
Websites whose visitors overlap most with Geno Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| torrentpharma.com | 100% | 31.6K | #932,209 | View details | |
| plethico.com | 99% | 1.1K | #12,004,230 | View details | |
sso.mims.com | sso.mims.com | 66% | – | ||
euphoricpharma.com | euphoricpharma.com | 63% | – | ||
drugfieldpharma.com | drugfieldpharma.com | 62% | #3,136,207 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Geno Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Geno Pharmaceuticals
Complete news archive for Geno Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geno Pharmaceuticals
Geno Pharmaceuticals was founded in 1975.
Geno Pharmaceuticals is headquartered in Mapusa, India. It is registered at Mapusa, Goa, India.
Geno Pharmaceuticals has 1,181 employees.
The primary company behind Geno Pharmaceuticals, Geno Pharmaceuticals Private Limited, reported revenue of ₹349 Cr for FY 2025, up 14% year on year.
Geno Pharmaceuticals Pvt. Ltd. is established as a key player in the pharmaceutical industry, with operations grounded in divisions like Geno Shakti, Geno Shaurya, and Clean Care that focus on healthcare and dermatological solutions. A network of 24 depots and over 1298 distributors is maintained across major Indian cities, supported by a field sales force of 680. Founded in 1975, the company is guided by experienced directors and has demonstrated commitments through CSR initiatives, such as donations during the COVID-19 pandemic, to enhance community health and animal well-being.
Geno Pharmaceuticals offers Geno Shakti and Geno Shaurya.
Geno Pharmaceuticals operates through Geno Pharmaceuticals Private Limited.
The legal entities of Geno Pharmaceuticals currently have 7 directors, including Dilip Salgaocar Ramacrisna, Sagar Dilip Salgaocar, Pramod Dilip Salgaocar and others.